C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
June 20, 2024 08:00 ET
|
Centogene NV
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug...
NBME collaborates with medical schools to advance workplace-based assessment in medical education
June 11, 2024 10:42 ET
|
NBME
PHILADELPHIA, June 11, 2024 (GLOBE NEWSWIRE) -- NBME is collaborating with five medical schools to explore the creation of a data-driven insights model to advance workplace-based assessment and data...
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
May 14, 2024 08:30 ET
|
Centogene NV
CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued...
NBME Appoints New Vice President of Competency-Based Assessment
April 16, 2024 10:55 ET
|
NBME
PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- NBME, a leading medical assessment company, has recently appointed Christopher Feddock, MD, to Vice President of Competency-Based Assessment (CBA) in...
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
March 19, 2024 06:30 ET
|
Centogene NV
Longstanding global partnership provides an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 19, 2024 ...
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
January 25, 2024 06:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare...
NBME Revitalizes Grants Program to Enhance Assessment in Latin America
January 18, 2024 13:46 ET
|
NBME
PHILADELPHIA, Jan. 18, 2024 (GLOBE NEWSWIRE) -- NBME renews the Latin America Grants Program to continue its commitment to advancing innovative approaches to medical education and enriching the...
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment
June 27, 2023 07:30 ET
|
Centogene NV
Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) based in RiyadhJV...
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
April 11, 2023 06:30 ET
|
Centogene NV
The global market access and expansion partnership, initially established in 2015, aims to provide an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) Diagnosis...
ITW Global Leaders Forum and MEF Sign MOU to Drive Development of Global Automated Ecosystem
March 08, 2023 09:06 ET
|
MEF
DUBAI, United Arab Emirates, March 08, 2023 (GLOBE NEWSWIRE) -- MEF, a global industry association of network, cloud, and technology providers accelerating enterprise digital transformation, and the...